Daniel E. Greenleaf, President and CEO at VioQuest Pharmaceuticals, Inc. (VQPH), bought 2,500 shares at $0.58 ($1K) on 2007-02-14, disclosed to the SEC on 2007-02-16.
Open-market purchase of $1k VQPH by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BIOS | BUY | 2016-11-14 | $21K | — | Filing → |
| VQPH | BUY | 2007-02-20 | $10K | — | Filing → |
| VQPH | BUY | 2006-04-06 | $9K | — | Filing → |